IDEXX beats expectations on Q4 results, raises 2020 guidance

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Friday posted better-than-expected fourth-quarter results and raised its 2020 outlook for revenue and earnings.

The Westbrook-based provider of veterinary diagnostics and water testing reported revenues of $605.4 million, up 10% from a year earlier on an organic and reported basis. That exceeds the $599.94 million Zacks Investment Research analysts’ consensus forecast.

The company posted earnings per diluted share of $1.04 on a reported basis, representing 6% growth over a year ago. That’s higher than the consensus forecast of 91 cents a share. Read more

Related Posts

Maine’s life sciences sector growth could outpace other industries

Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...

13 January 2025

IDEXX gets wiggle room to buy back more shares

IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...

10 December 2024

Maine’s first accredited lab for PFAS testing is expanding to meet demand

NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...

6 December 2024